Previous 10 | Next 10 |
Company Benefits from Unique Chinese, Hong Kong, Macau Diagnostic Patent Rights, and Closes Deal to Help America Now NEW YORK, NY, March 23, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an outcome-...
FDA Approved VT-1000 Qualitative and Quantitative Analyzer NEW YORK, New York, March 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare company, today announced i...
NEW YORK, NY, March 17, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare company, today announced that in collaboration with Harvard In Tech, Harvard University's offic...
Patented and FDA Approved Diagnostics Platform Subject of Application for Contract Grant with U.S. Center for Disease Control, (CDC ) NEW YORK, NY, March 16, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Compa...
Parallax Health Sciences (OTCQB: PRLX), an outcome-driven connected healthcare company, on Thursday announced that its wholly owned subsidiary, Parallax Health Management, Inc., focused on Remote Patient Monitoring (“RPM”) has the proprietary and patented Good Health Outcomes(TM)...
$8.3 Billion in Federal Emergency Funding from U.S. Congress Combined with Private Insurance Reimbursement Commitments Gives Boost to Telehealth Programs Addressing the COVID-19 Pandemic NEW YORK, NY, March 12, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax Health ...
Thinly traded nano cap Parallax Health Sciences ( OTCPK:PRLX +13% ) is, yet another, would-be player in the mad dash for a rapid screening test for COVID-19. More news on: Parallax Health Sciences, Inc., Aytu BioScience, Inc., Co-Diagnostics, Inc., Healthcare stocks news, Stocks on ...
Company will Partner to Accelerate The Deployment of Diagnostic Solutions Under Patent Protected Service Areas Including China, Hong Kong, India, and US NEW YORK, NY, March 11, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Paralla...
Company Eliminates $25 Million Contingent Liability and Focuses Toward Operating Growth Parallax Licensing Program Moving Forward on All Fronts NEW YORK, NY, Feb. 24, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' ...
Critical Access Hospitals, Doctor Offices and Nursing Operations Contract with Parallax for Chronic Disease Management Capitalizing on New Reimbursement Landscape NEW YORK, NY, Feb. 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax Health Sciences, Inc. (OTCQB: PRLX) (...
News, Short Squeeze, Breakout and More Instantly...
Parallax Health Sci Inc Company Name:
PRLX Stock Symbol:
OTCMKTS Market:
Company Receives Over $10 million of Telehealth and Medical Supply Contracts from Coast to Coast New York, NY - ( NewMediaWire ) - April 9, 2020 - Parallax Health Sciences, Inc. (OTCQB: PRLX) (“Parallax” or the “Company”), an outcome-driven ...
COVID-19 Coronavirus Infection Risk May be Reduced by Weekly Dose of Vitamin D3 New York, NY - ( NewMediaWire ) - April 7, 2020 - Parallax Health Sciences, Inc. (OTCQB: PRLX) (“Parallax” or the “Company”), announced that its wholly owned subsidiary Para...
COVID-19 Coronavirus Infection Risk May be Reduced by Weekly Dose of Vitamin D3 NEW YORK, NY, April 07, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health Sciences, Inc. (OTCQB: PRLX) (“Parallax” or the “Company”), announced that its wholly...